# Texas hemp companies sue over smokable cannabis ban and higher fees – KUT 90.5 > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/texas-hemp-companies-lawsuit-smokable-cannabis-ban-fees/ > **Published:** 2026-04-09T13:44:04-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:26:33-04:00 > **Clinical Summary:** Texas hemp companies lawsuit challenges smokable cannabis ban and higher fees, impacting product availability and patient access in Texas. --- ✦ New CED Clinical Relevance #45 [Clinical Context](https://cedclinic.com/cannabis-hyperemesis-syndrome-treatment-insights-2026/) Background information relevant to the evolving [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) landscape. PolicyHempTHCIndustry Why This Matters Clinicians in Texas need to understand that legal challenges to hemp product regulations may affect the availability and labeling of cannabis products their patients can access, potentially creating gaps in the consistency and safety of what patients purchase. The “total THC” restriction and fee structures being challenged could influence which cannabis products remain available in the market and at what price points, directly impacting patient adherence to cannabis-based treatment regimens. As these regulatory disputes evolve, clinicians should stay informed about their local hemp and cannabis policies to provide accurate guidance on product legality and availability when discussing [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) with patients. Clinical Summary Texas hemp companies are challenging the state’s regulatory framework that restricts smokable cannabis products and imposes higher licensing fees, citing ambiguity in how “total THC” is calculated under federal farm bill compliance. The lawsuit highlights tension between federal hemp regulations that permit products with less than 0.3% THC by dry weight and Texas’s interpretation of these standards, which some argue unfairly targets smokable flower while allowing other cannabinoid products. This regulatory uncertainty affects product availability and market access for patients seeking alternative cannabis delivery methods beyond traditional oils or edibles. If the courts rule in favor of the hemp companies, Texas could be forced to recalibrate its enforcement approach, potentially expanding [patient access](https://cedclinic.com/iowa-medical-cannabis-dispensaries-expansion/) to smokable hemp-derived products and reducing compliance costs for producers. Clinicians should be aware that regulatory landscapes governing cannabis products continue to shift rapidly across states, which may affect what patients can legally access and what formulations they bring to clinical appointments. Staying informed about ongoing litigation and regulatory changes in your state remains essential for counseling patients about legal product availability and potential future access to different cannabis delivery methods. Dr. Caplan’s Take “What we’re seeing in Texas is a regulatory framework that’s scientifically inconsistent and clinically problematic: you can’t ban a delivery method based on plant material while allowing the same cannabinoids through other routes, and doing so based on arbitrary THC thresholds rather than actual patient outcomes or safety data undermines the evidence-based approach we need in cannabis medicine.” Clinical Perspective The legal challenge to Texas’s smokable cannabis restrictions highlights an important gap between regulatory intent and clinical reality that clinicians should understand when counseling patients. While state bans on smokable [hemp products](https://cedclinic.com/texas-hemp-stricter-thc-rules-march-31-2026/) aim to prevent cannabis misuse by closing loopholes in federal hemp regulations, the litigation underscores how definitional ambiguities around “total THC” versus “delta-9 THC” create enforcement challenges and market confusion that ultimately affect patient access to legal products and their ability to make informed choices. Clinicians should recognize that patients may encounter products marketed as legal hemp that contain psychoactive cannabinoids, and that the patchwork of state-level regulations means guidance differs considerably by geography. Until clearer federal or state definitions emerge, providers should assume patients may have access to a wider range of cannabinoid products than traditional cannabis, and should screen explicitly for smokable cannabis use and product composition when taking substance use histories or advising patients on 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just+read+this+on+CEDclinic.com%3A+Texas+hemp+companies+sue+over+smokable+cannabis+ban+and+higher+fees+-+KUT+90.5+%40drcaplan&url=https%3A%2F%2Fwww.kut.org%2Fbusiness%2F2026-04-08%2Faustin-tx-texas-hemp-ban-cannabis-lawsuit-thca-businesses)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fwww.kut.org%2Fbusiness%2F2026-04-08%2Faustin-tx-texas-hemp-ban-cannabis-lawsuit-thca-businesses)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just+read+this%3A+Texas+hemp+companies+sue+over+smokable+cannabis+ban+and+higher+fees+-+KUT+90.5+--+via+%40drcaplan.bsky.social+https%3A%2F%2Fwww.kut.org%2Fbusiness%2F2026-04-08%2Faustin-tx-texas-hemp-ban-cannabis-lawsuit-thca-businesses)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://www.kut.org/business/2026-04-08/austin-tx-texas-hemp-ban-cannabis-lawsuit-thca-businesses](https://www.kut.org/business/2026-04-08/austin-tx-texas-hemp-ban-cannabis-lawsuit-thca-businesses) Further Reading Research Digest[Research Digest: 5 Recent Studies – March 25, 2026](https://cedclinic.com/real-time-long-term-effects-medical-marijuana-research/) CED Clinic Blog[Musshoff and Madea – 2006 – Review of Biologic Matrices Urine Blood Hair as Indicators of Recent or Ongoing Cannabis Use](https://cedclinic.com/biologic-matrices-cannabis-indicators-review-2006/) Evidence Watch[Cannabis Products and Contaminant Detection: Critical Review of Regulatory Oversight and Analytical Methodologies.](https://cedclinic.com/cannabis-contaminant-testing-regulations-review/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Texas hemp businesses sue state over new ban on smokable THC products – CBS News](https://cedclinic.com/smokable-hemp-derived-thc-products-ban-texas/) Detailed coverage of the Texas hemp businesses' legal challenge against the state's ban on smokable THC products. [Read More](https://cedclinic.com/smokable-hemp-derived-thc-products-ban-texas/) [Texas Hemp Ban Enforceable During Legal Challenge Court Rules](https://cedclinic.com/texas-hemp-ban-enforceable-during-legal-challenge/) Court ruling on the enforceability of the Texas hemp ban amid ongoing legal challenges. [Explore Details](https://cedclinic.com/texas-hemp-ban-enforceable-during-legal-challenge/) [Texas hemp businesses in limbo awaiting final decision on new rules that hike fees 13000%](https://cedclinic.com/texas-hemp-licensing-fees-business-impact-2026/) Insight into the uncertainty faced by Texas hemp businesses due to new regulatory fee hikes and pending legal decisions. [Learn More](https://cedclinic.com/texas-hemp-licensing-fees-business-impact-2026/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).